HomeProductsBuilding BlocksHeterocyclic ScaffoldsPyrrolidinesRemoxipride
Chemical structure of CAS 80125-14-0

Remoxipride

CAS No.80125-14-0
MDL No.N/A
MFC16H23BrN2O3
MW371.27
InChI KeyGUJRSXAPGDDABA-NSHDSACASA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

3-bromo-2,6-dimethoxybenzamide-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl] is a dimethoxybenzene.

CAS No.80125-14-0
Product NameRemoxipride

Biological Targets

DRD2

Associated Conditions

psychosis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Effects of antipsychotic drugs on operant responding after acute and repeated administration.

Psychopharmacology • Vol. 160, Issue 2 • 2002
PMID: 11875636DOI: 10.1007/s00213-001-0969-y

Atypical kinetics for a series of putative dopamine antagonists to reverse the low-magnitude Ca2+ phase in the dopamine-bound D2short receptor state.

Naunyn-Schmiedeberg's archives of pharmacology • Vol. 365, Issue 1 • 2002
PMID: 11862337DOI: 10.1007/s00210-001-0487-9

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.

British journal of pharmacology • Vol. 135, Issue 1 • 2002
PMID: 11786492PMC: PMC1573106DOI: 10.1038/sj.bjp.0704442

Atypical antipsychotics: mechanism of action.

Canadian journal of psychiatry. Revue canadienne de psychiatrie • Vol. 47, Issue 1 • 2002
PMID: 11873706

Documentation